U.S. approves Pfizer-BioNTech vaccine for children aged 5-11

Download

02:32

The U.S. has approved the Pfizer-BioNTech vaccine for children aged five to 11. The U.S. Centers for Disease Control and Prevention on Tuesday recommended the shot for broad use in that age group after a panel of outside advisers voted in favor of it.

Open in CGTN APP for better experience

Search Trends